Notices and Reminders
Reminder: Research Integrity Training Requirement
All individuals at OUHSC who conduct or oversee research, who are eligible to conduct or oversee research - including managing research accounts (administrative and/or financial aspects of research accounts), must complete Research Integrity Training. Learn more at: https://research.ouhsc.edu/Research-Integrity or https://research.ouhsc.edu/Research-Integrity/Research-Integrity-Training-FAQs
Key Points:
- PI’s are responsible for ensuring all members of their research team have completed Research Integrity Training
- The required course is valid for four years from the date of completion; after four years, OUHSC affiliates will receive a notice directly from the CITI Program about course expiration and are required to take the refresher course.
- Business Managers should assign Research Integrity Training via ePAF to everyone in their unit whose duties fit the requirements to ensure the department’s compliance is recorded in PeopleSoft
- Anyone with an OUHSC email address can register with CITI Program, affiliate with the University of Oklahoma Health Sciences Center, and then add the required course: “Responsible Conduct of Research”; step-by-step instructions are attached
- Contact the Research Integrity Office for assistance or questions: ResearchIntegrity@ouhsc.edu or 405-271-7755
Workshops and Seminars
Save the Date - ORA Noon Conference offered via Zoom
Date: April 27, 2022 at 1:00 pm
Topic: Introduction to Grant Writing
Description: This talk is designed to present a brief overview of the grant writing process and considerations for new investigators or those new to grant writing. We will also touch upon the NIH recommendations for the format of the research plan, discuss the three key questions that reviewers are asked to consider when reviewing grant applications, describe new and early stage investigator status, and introduce NIH Matchmaker and ART.
Registration: https://zoom.us/meeting/register/tJwrcu2hpz8iH9bi9cGiL_anAd3lAhHF1gZw
Save the Date - ORA Evening Conference offered via Zoom
Date: April 28, 2022 at 5:15 pm
Topic: Grant Writing for Success
Description: This talk goes beyond the basics of grant writing to discuss writing the specific aims and considerations for the research strategy, convey the NIH-recommended format and approach for each subsection, address and explain core-review criteria, and discuss scoring conventions, rigor, and reproducibility.
Registration: https://zoom.us/meeting/register/tJYudOyqrT4jGdK_QrwoymDkWyW6hj6ybLma
The Office of Technology Commercialization - Join us for the next Innovation to Impact Copyright, Trademark, & Open Source
Date: April 27, 2022; 12 p.m. (CDT)
Description: We invite you to join us for an upcoming session of Innovation to Impact, a series of lunch discussions for faculty, staff and graduate students about the creation, management and commercialization of intellectual property (IP).
Copyright, Trademark & Open Source
- Not all intellectual property is patentable
- Filing for copyrights and trademarks
- Protecting your software application
- Examples of licensing non-traditional IP
During these presentations, you will learn more about the impact of IP and how it complements your research. Meet members of the Office of Technology Development team and enjoy complimentary lunch. Space is limited, so reserve your spot now.
Join Zoom Meeting: https://oklahoma.zoom.us/meeting/register/tJMtde2sqzMsGtW3idEcX_jzSA1vHFnyWN5T
OUHSC Funding Opportunities
Call for Pre-Proposals - Pew-Stewart Scholars Program for Cancer Research
Description: The Pew-Stewart Scholars Program for Cancer Research supports assistant professors of outstanding promise in science relevant to the advancement of a cure for cancer. The award provides $300,000 in flexible support—$75,000 per year for a four-year period. In line with the Stewart Trust's mission to invest in innovative, cutting-edge, basic cancer research that may accelerate and advance progress toward a cure for cancer, applications are invited from one nominee at OUHSC conducting cancer research.
Eligibility:
- Candidates must have been awarded a doctorate in biomedical sciences or medicine.
- As of September 3, 2021, nominees must hold a full-time appointment at the rank of assistant professor.
- Note: Modified title appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are NOT ELIGIBLE.
- On June 15, 2021, candidates must have been in such an appointment for less than three years (not appointed before June 15, 2018). Time spent in clinical internships, residencies, in work toward board certification, or on parental leave does not count as part of this three-year limit. Candidates who took parental leave should contact Pew's program office to ensure that application reviewers are aware of their circumstances.
Pre-proposal Application Details:
- Interested applicants should submit all pre-proposal materials, including:
- Research project summary – 500 word limit
- Specific Aims page – 1 page limit (11 pt font or larger)
- Curriculum vitae
- Letter of support from the Departmental Chair and/or Section Chief
- Submit all materials as a single PDF file to:
Stevie Warner, Programs and Initiatives Manager
SCC Education and Training Core
stevie-warner@ouhsc.edu
- An internal selection committee consisting of six senior faculty in diverse cancer research areas will evaluate pre-proposals and select the most suitable applicant to nominate for the Pew-Stewart Scholars Program for Cancer Research.
Should you have any questions, please contact Stevie Warner (stevie-warner@ouhsc.edu; (405) 271-2537).
Pre-proposal Submission Deadline: May 1, 2022
Request for Proposals for COBRE Pilot Projects: Expanding Excellence in Developmental Biology in Oklahoma
Description: We are inviting the submission of pilot project proposals for funding through the Pilot Project Core of our Developmental Biology COBRE. Proposals should address novel, exciting research questions that are related to Developmental Biology and have outstanding potential to attract future NIH/NSF funding. Primary preference will be to junior investigators without prior NIH R01 or equivalent Federal support. Secondary preference will be for investigators at any level who are initiating new projects in Developmental Biology that require the generation of preliminary data for the subsequent submission of an investigator-initiated large-scale grant. Individuals with current COBRE or INBRE support are not eligible.
Application Submission Deadline: April 25, 2022
Link to Full Announcement: Please refer to the attached flyer.
Office of Technology Commercialization presents the following opportunities for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).
- A life sciences measurement and tools company (requested anonymity) is seeking novel approaches for scalable synthesis of oligonucleotides. Of particular interest is use of enzymatic approaches, including those that combine chemical and enzymatic synthesis methods. Innovative approaches to traditional oligonucleotide synthesis may be of interest if demonstrated benefits. Submission entails a 1-pg non-confidential summary of technology (deadline 5/16)
NIH Notices
NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted). The letters of intent will be reviewed and a single application will be chosen for submission from the University.
NIH Funding Opportunities
- AHRQ Administrative Supplements for Grants in Health Services Research
(PA-22-168)
Application Receipt Date(s): June 26, October 26, February
- Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
(PAR-22-131)
Application Receipt Date(s): Multiple dates, see announcement.
- Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
(PAR-22-136)
Application Receipt Date(s): New: June 15, 2022; June 15, 2023, June 17, 2024 Resubmission/Renewal: June 15, 2022; June 15, 2023, June 17, 2024
- NEI Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U01 Clinical Trial Required)
(PAR-22-149)
Application Receipt Date(s): May 07, 2025
- IDeA Clinical Research Resource Center (U24 Clinical Trial Not Allowed)
(PAR-22-150)
Application Receipt Date(s): September 26, 2022
- Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
(PAR-22-162)
Application Receipt Date(s): February 28, 2025
- Specialized Alcohol Research Centers (P50 Clinical trial Optional)
(RFA-AA-22-001)
Application Receipt Date(s): November 15, 2022
- Comprehensive Alcohol Research Centers (P60 Clinical trial Optional)
(RFA-AA-22-002)
Application Receipt Date(s): November 15, 2022
- Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed)
(RFA-AG-23-016)
Application Receipt Date(s): October 18, 2024
- Limited Interaction Targeted Epidemiology: Viral Suppression (LITE-VS) (UG3/UH3 Clinical Trial Optional)
(RFA-AI-22-024)
Application Receipt Date(s): August 03, 2022
- Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
(RFA-DK-22-011)
Application Receipt Date(s): July 28, 2022
- Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot Spots in the United States (R01 - Clinical Trial Required)
(RFA-MD-22-009)
Application Receipt Date(s): August 15, 2022
- Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed)
(RFA-RM-22-014)
Application Receipt Date(s): July 19, 2022
- IND-enabling Studies of Somatic Genome Editing Therapeutic Leads (U19, Clinical Trial Not allowed)
(RFA-RM-22-015)
Application Receipt Date(s): July 19, 2022
- Platform Clinical Trials of Genome Editors in Multiple Diseases (UG3/UH3, Clinical Trial Required)
(RFA-RM-22-016)
Application Receipt Date(s): July 19, 2022
- Somatic Cell Genome Editing Program Translational Coordination and Dissemination Center (TCDC) (U24 - Clinical Trial Not Allowed)
(RFA-RM-22-017)
Application Receipt Date(s): July 19, 2022
- NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
(RFA-RM-22-018)
Application Receipt Date(s): Multiple dates, see announcement.
- Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
(RFA-RM-22-024)
Application Receipt Date(s): July 15, 2022
Other Funding Opportunities
Chan Zuckerberg Initiative (CZI) - Request for Applications: Patient-Partnered Rare Neurodegenerative Disease RFA
Description: The Chan Zuckerberg Initiative invites applications from collaborative teams bringing together patient-led rare disease organizations and research teams for 4-year research projects aimed at advancing our understanding of the fundamental science of rare diseases. The Patient-Partnered Collaborations for Rare Neurodegenerative Disease RFA aims to advance the understanding of the pathophysiology and mechanistic underpinnings of rare neurodegenerative and neurological disorders. Awards are $2,000,000 USD total costs for four years for each project (distributed amongst research institutions and a patient organization). The award period for each RFA is an initial two years of funding, followed by an additional two years, pending evaluation. Applicants are welcome to apply to both this opportunity and the Patient-Partnered Collaborations for Single-Cell Analysis of Rare Inflammatory Pediatric Disease RFA; however, the application and scope of work must be distinct.
Application deadline: May 24, 2022
Link to Full Announcement: https://chanzuckerberg.com/rfa/patient-partnered-collaborations-ppc-for-rare-neurodegenerative-disease
Health Resources and Services Administration (HRSA) Public Health Scholarship Program (PHSP)
Description: The purpose of the PHSP is to strengthen the public health workforce by providing support to organizations to develop scholarship programs that incentivize individuals to pursue training and careers in public health. Through the PHSP, scholarship recipients will gain the requisite knowledge and skills necessary to prevent, prepare for, and respond to recovery activities related to COVID–19, as well as other public health emergencies.
Application deadline: June 1, 2022
Link to Full Announcement: https://www.hrsa.gov/grants/find-funding/hrsa-22-122
APsaA Fund for Psychoanalytic Research: Research Grant, Pilot Grant, Consultation Grant, Career Support Grant
Description: The Fund conceives of psychoanalytic research along the broadest lines, including: scholarly and empirical investigative contributions that can advance knowledge of psychoanalytic theory, practice, and links between psychoanalysis and neighboring disciplines such as developmental psychology or neuroscience.
Applications Due: May 1, 2022
Link to Full Announcement: https://apsa.org/research-fund
The Cystic Fibrosis Foundation (CFF) Clinical Trials in Organ Transplant (CTOT)
Description: The CF Foundation is seeking applications for lung transplant research projects that aim to use available CTOT specimens and/or data to improve knowledge of Chronic Lung Allograft Dysfunction (CLAD) pathogenesis and explore new approaches to detection, prevention, monitoring or treatment of CLAD. For questions, please contact lungtransplant@cff.org
LOI deadline: April 20, 2022
Full Application deadline: August 23, 2022.
Link to Full Announcement: https://www.cff.org/sites/default/files/2022-03/Clinical-Trials-in-Organ-Transplantation-Ancillary-Studies-Policies-and-Guidelines.pdf
The Vilcek Foundation 2023 Vilcek Prizes for Creative Promise in Biomedical Science
Description: The Vilcek Foundation will award three Creative Promise Prizes of $50,000 each to young, immigrant biomedical scientists who demonstrate outstanding early achievement. Applicants should have been born outside of the United States and be 38 years of age or younger, but limited exceptions to the age requirement will be granted to those who have taken time off for caregiving, medical, military, or parental leave. Three winners will each receive a $50,000 unrestricted cash prize and be honored at an awards ceremony in New York City in April 2023.
Deadline: June 10, 2022
Link to Full Announcement: https://vilcek.org/prizes/vilcek-prizes-for-creative-promise/creative-promise-prizes-biomedical-science/
Pandemic Antiviral Discovery (PAD) Henipavirus – Request for proposals 2022
Description: This RFP will support projects that seek to elucidate the molecular determinants of henipavirus replication, pathogenesis and transmission for the purpose of developing therapeutic discovery programs targeting virus and/or host-specific targets important for virus replication. Projects can be of both novel and exploratory nature and of later-stage validation/developmental nature.
Deadline: May 5, 2022
Link to Full Announcement: https://padinitiative.com/henipavirus-request-for-proposals-2022/
DoD FY22 Prostate Cancer Research Program (PCRP)
- Exploration – Hypothesis Development Award (EHDA)
Pre-Application (Letter of Intent [LOI]): June 2, 2022
Application: June 23, 2022
- Early Investigator Research Award (EIRA)
- Physician Research Award (PRA)
Pre-Application (LOI): July 7, 2022
Application: July 28, 2022
Letters of Recommendation: August 2, 2022
- Translational Science Award (TSA)
- Health Disparity Research Award (HDRA)
- Data Science Award (DSA)
Pre-Application (LOI): August 4, 2022
Application: August 25, 2022
- Idea Development Award (IDA)
Pre-Application (LOI): July 7, 2022
Application: July 28, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/pcrp
DoD FY22 Peer Reviewed Orthopaedic Research Program (PRORP)
- Applied Research Award (ARA)
- Clinical Trial Award (CTA)
- Clinical Translational Research Award (CTRA)
Pre-Application (Preproposal): June 16, 2022
Application: September 13, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/prorp
DoD FY22 Peer Reviewed Cancer Research Program (PRCRP)
- Behavioral Health Science Award (BHSA)
- Career Development Award (CDA) – Fellow Option
- Career Development Award (CDA) – Virtual Cancer Center Scholar Option
- Translational Team Science Award (TTSA)
Pre-Application (Letter of Intent): July 12, 2022
Application: August 2, 2022
- Convergent Science Cancer Consortium Development Award (CSCCDA)
Pre-Application (Letter of Intent): August 17
Application: September 7, 2022
- Idea Award (IA)
- Impact Award (IPA)
Pre-Application (Preproposal): May 25, 2022
Invitation to Submit: July 11, 2022
Application: September 7, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/prcrp
DoD FY22 Autism Research Program (ARP)
- Clinical Trial Award (CTA)
- Idea Development Award (IDA)
- Career Development Award (CDA)
Pre-Application (Preproposal): May 23, 2022
Invitation to Submit an Application: June 2022
Application: August 18, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/arp
DoD FY22 Spinal Cord Injury Research Program (SCIRP)
- Clinical Trial Award (CTA)
- Translational Research Award (TRA)
- Investigator-Initiated Research Award (IIRA)
Pre-Application (Preproposal): May 23, 2022
Application: September 2, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/scirp
DoD FY22 Joint Warfighter Medical Research Program (JWMRP)
- Military Medical Research and Development Award (MMRDA)
Pre-Application (Preproposal): May 16, 2022
Application: July 28, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/jwmrp
DoD FY22 Ovarian Cancer Research Program (OCRP)
- Pilot Award (PA)
- Proteogenomics Research Award (PGRA)
- Ovarian Cancer Academy Award - Early-Career Investigator (OCA)
- Investigator-Initiated Research Award (IIRA)
Pre-Application (Preproposal): May 2, 2022
Application: August 5, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/ocrp
DoD FY22 Orthotics and Prosthetics Outcomes Research Program (OPORP)
- Clinical Research Award (CRA)
- Clinical Trial Award (CTA)
Pre-Application (Letter of Intent): May 4, 2022
Application: June 1, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/oporp
DoD FY22 Epilepsy Research Program (ERP)
- Idea Development Award (IDA)
- Research Partnership Award (RPA)
- Virtual Post- Traumatic Epilepsy Research Center Leadership Award
(Virtual-P-TERC-L)
- Virtual Post- Traumatic Epilepsy Research Center Faculty Award
(Virtual-P-TERC-F)
Pre-Application (Letter of Intent): May 19, 2022
Application: June 23, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/erp
DoD FY22 Breast Cancer Research Program (BCRP)
- Breakthrough Award Levels 1 and 2 (BTA12)
- Era of Hope Scholar Award (EOHSA)
Pre-Application (Letter of Intent): May 3, 2022
Application: May 17, 2022
Confidential Letters of Recommendation Submission Deadline: May 20, 2022
- Breakthrough Award Level 3 (BTA3)
- Breakthrough Award Level 4 (BTA4)
- Innovator Award (INNOV)
- Transformative Breast Cancer Consortium Award (TBCCA)
Pre-Application (Preproposal): April 28, 2022
Invited Application: July 27, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/bcrp
DoD FY22 Amyotrophic Lateral Sclerosis Research Program (ALSRP)
- Pilot Clinical Trial Award
- Clinical Biomarker Development Award
- Therapeutic Development Award
- Therapeutic Idea Award
Pre-Application (Preproposal): April 29, 2022
Invitation to Submit an Application: June 2022
Application: July 28, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/alsrp
DoD FY22 Lung Cancer Research Program (LCRP)
- Career Development Award (CDA)
- Concept Award (CA)
Pre-Application (Letter of Intent): May 3, 2022
Letter of Intent is required.
Application: May 17, 2022
- Clinical Translational Research Partnership Award (CTRPA)
Pre-Application (Letter of Intent): July 13, 2022
Letter of Intent is required.
Application: July 27, 2022
- Idea Development Award (IDA)
- Investigator-Initiated Translational Research Award (IITRA)
Pre-Application (Preproposal): May 4, 2022
Preproposal is required; application submission is by invitation only.
Application: July 27, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/lcrp
DOD FY22 Peer Reviewed Medical Research Program (PRMRP)
- Clinical Trial Award (CTA)
- Focused Program Award (FPA)
Pre-Application (Preproposal): May 6, 2022
Application: August 12, 2022
Pre-Application (Letter of Intent): April 22, 2022
Application: May 20, 2022
- Investigator-Initiated Research Award (IIRA)
- Technology/Therapeutic Development Award (TTDA)
Pre-Application (Letter of Intent): April 29, 2022
Application: May 27, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/prmrp
HHS/CDC (Forecasted) Building Mathematical Modeling Workforce Capacity to Support Infectious Disease and Healthcare Research
Description: The purpose of this notice of funding opportunity is to support pre-doctoral fellows’ innovative research to develop and apply computational tools and mathematical methods for modeling the spread of pathogens in healthcare settings (e.g., SARS-CoV-2, healthcare-associated infections [HAIs], antimicrobial resistant organisms [AROs]). This NOFO is intended to increase the number of junior modeling professionals that are trained and experienced in modeling transmission of pathogens in healthcare settings and to contribute to generalizable scientific knowledge through dissemination (e.g., pre-prints, peer-reviewed studies, scientific presentations). The application should be written by the PI/mentor who may or may not name specific pre-doctoral student(s) to conduct the research at the time of application submission.
Estimated Application Due Date: May 4, 2022
Link to Full Announcement: https://www.grants.gov/web/grants/view-opportunity.html?oppId=337897
Robert Wood Johnson Foundation Funding Opportunities
The Robert Wood Johnson Foundation funds a wide array of research and initiatives to help address some of America’s most pressing health challenges.
The Interdisciplinary Research Leaders program seeks teams of researchers and community members committed to working together improve health equity by dismantling structural racism.
Application Due Date: Wed, 4 May 2022
Evidence for Action prioritizes research to evaluate specific interventions that have the potential to contribute to dismantling and counteracting the harms of structural and systemic racism and improving health, well-being, and equity outcomes.
Application Due Date: Proposals will be accepted throughout the year on a rolling admission
Pioneering Ideas: Exploring the Future to Build a Culture of Health welcomes proposals that are primed to influence health equity in the future.
Application Due Date: Proposals will be accepted throughout the year on a rolling admission
Link to Full Announcement: https://www.rwjf.org/en/how-we-work/grants-explorer/funding-opportunities.html
The International Center for Responsible Gaming (ICRG) 2022 Grants Program
Description: The ICRG awards grants on a competitive basis for a variety of research activities exploring the etiology, prevention and treatment of gambling disorder and the development and evaluation of responsible gambling strategies.
Large Grant: Up to $75,000/per year in direct costs for 2 years
Deadline for Letters of Intent: April 1, 2022
Application Deadline: June 30, 2022
Seed Grant: Up to $30,000/per year in direct costs for one year
Application Deadline: May 2, 2022
Link to Full Announcement: https://www.icrg.org/research-center/apply-icrg-funding
The International Foundation for Ethical Research (IFER) – 2022-2023 GRADUATE FELLOWSHIPS FOR ALTERNATIVES TO THE USE OF ANIMALS IN SCIENCE
Description: IFER Graduate Fellowships are one-year grants for projects that support the development, acceptance and implementation of innovative scientific methodologies that advance science and refine, reduce or replace the use of animals in research, testing or education. Grants of $12,500 are typically awarded and are renewable annually for up to three years, depending on student progress and availability of funds. IFER recognizes the value in directing financial resources away from animal models and toward the development of human-relevant, non-animal models, as such resources pay higher dividends for human health when used for human-relevant research.
Pre-proposals Due: April 30, 2022
Link to Full Announcement: More information on the IFER Graduate Fellowship program, including eligibility requirements, submission guidelines, and a link to the online application can be found on the IFER website at www.ifer.org/fellowships.php.